Framework contracts for innovative infectious disease therapeutics
Original notice title
Belgium – Research and development services and related consultancy services – Multiple sourcing Framework Contracts to speed up the development of and access to innovative medical countermeasures Next Generation Therapeutics for Infectious Diseases
Opportunity Score
Why this score?
Opportunity
75 / 100
Complexity
85 / 100
Risk factors
Highly innovative and specialized therapeutic areas (e.g., host-targeted, broad-spectrum) may require cutting-edge R&D...
Procurement documents are not analyzed; detailed requirements, terms, and conditions may impose unforeseen obligations.
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Overview
Strong opportunityKey Facts
- EUR 252M estimated value
- Framework procurement
- Services contract
- 2 lots
- Lot 1: Development of pathogen-targeted scalable therapeutics, innovative combination therapies, and alternative IV route products for viral infections, ARDS, or sepsis.
- Lot 2: Development of host-targeted scalable therapeutics, innovative combination therapies, and alternative IV route products for viral infections, ARDS, or sepsis.
Show full summary
This Pre-Commercial Procurement (PCP) call, led by the Health and Digital Executive Agency (HaDEA), aims to accelerate the development of innovative medical countermeasures for infectious diseases, specifically next-generation therapeutics. The tender consists of two lots: 'Highly Innovative Therapeutics' (Lot 1, value €138M) focusing on pathogen-targeted scalable therapeutics, and 'Advanced Therapeutics' (Lot 2, value €114M) focusing on host-targeted scalable therapeutics. Both lots include combination therapies and alternative IV routes. The overall estimated value is €252M, funded under EU4Health. The procedure is a negotiated procedure with call for competition, resulting in multiple sourcing framework contracts. Evaluation is 80% quality and 20% price. Submission deadline: 2026-09-02.
Risks
Highly innovative and specialized therapeutic areas (e.g., host-targeted, broad-spectrum) may require cutting-edge R&D...
Procurement documents are not analyzed; detailed requirements, terms, and conditions may impose unforeseen obligations.
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
Technical
- Must address viral infections, ARDS, or sepsis resulting from infections.
- Pathogen-targeted therapeutics (Lot 1) or host-targeted therapeutics (Lot 2).
- Excludes small molecules, monoclonal antibodies; includes direct/indirect antivirals, immune modulators.
Award Criteria
Lot 1
Lot 2
Buyer
Location
Brussels, BEL
Website
Identifier
HADEA
Activity
General public services
Lots (2)
LOT-0001
Highly Innovative Therapeutics
Lot 1 targets pathogen-targeted scalable therapeutics, innovative combination therapies, and therapeutics designed for alternative routes to IV administration.
EUR 252M
Estimated value
Duration
Category
Award Criteria
Deadline
Award details
Please consult the procurement documents.
Additional CPV codes
Value note
Show original TED data
Original TED description
Lot 1 targets pathogen targeted scalable therapeutics, innovative combination therapies and therapeutics designed to be administered through alternative routes to IV
LOT-0002
Advanced Therapeutics
Lot 2 targets host-targeted scalable therapeutics, innovative combination therapies, and therapeutics designed for alternative routes to IV administration.
EUR 252M
Estimated value
Duration
Category
Award Criteria
Deadline
Award details
Please consult the procurement documents.
Additional CPV codes
Value note
Show original TED data
Original TED description
Lot 2 targets host targeted scalable therapeutics, innovative combination therapies and therapeutics designed to be administered through alternative routes to IV
Procurement Details
- Publication date
- 01 Jul 2026
- Languages
- English, Bulgarian
Reference metadata
- Legal basis
- 32024R2509
Reference IDs
- Tender ID
- 456593-2026
Documents (2)
Similar tenders
Finland – Architectural, construction, engineering and inspection services – Tietomallikoordinaattori-, inventointimittaus- ja mallinnuspalvelujen puitejärjestely 2026-2028 (2028-2030)
Greece – Cultural event organisation services – ΛΕΙΤΟΥΡΓΙΑ ΤΟΥ ΘΕΑΤΡΟΥ ΟΛΥΜΠΙΑ ΜΑΡΙΑ ΚΑΛΛΑΣ ΜΕ ΕΞΕΙΔΙΚΕΥΜΕΝΟ ΠΡΟΣΩΠΙΚΟ
Romania – Street-cleaning and sweeping services – Acord cadru de prestare a serviciilor de delegare a activităților de măturat, spălat, stropit si întreținerea căilor publice și activități de curățare și transport al zăpezii de pe căile publice și menținerea în funcțiune a acestora pe timp de polei sau îngheț, pe timp de iarnă din cadrul serviciului de salubrizare a orașului Negrești Oaș
Spain – Architectural, construction, engineering and inspection services – Redacción del Proyecto Básico y de Ejecución, Redacción del Estudio de Seguridad y Salud y Dirección de Obra para la construcción del I.E.S. Nº 1 de 12+0 uds. (Fase 1) en la urbanización El Bosque de Pioz (Guadalajara).
France – Insurance services – MARCHE DE SERVICES EN ASSURANCE
Spain – Building-cleaning services – Servicios de limpieza en Centros de Sevilla, Murcia y Galicia, de la Agencia Estatal Consejo Superior de Investigaciones Científicas.
Opportunity Score
Why this score?
Opportunity
75 / 100
Complexity
85 / 100
Risk factors
Highly innovative and specialized therapeutic areas (e.g., host-targeted, broad-spectrum) may require cutting-edge R&D...
Procurement documents are not analyzed; detailed requirements, terms, and conditions may impose unforeseen obligations.
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications